Insight on Pharmaceuticals and Healthcare in Europe

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
Report
Report

The Contract Biomanufacturing Market Outlook to 2017

The biologic drug market is growing at nearly twice the pace of the overall pharma market. This report forecasts microbial and mammalian contract manufacturing markets to 2017. Market dynamics and leading players are also examined.

Published By Datamonitor
19 Feb 2013 $2800
Buy
Case Studies
Case Studies

The "Patent Cliff": How Pfizer has responded to the loss of its best-selling drug

The pharmaceuticals market is currently in the middle of a "patent cliff." This case study looks at the various routes companies are taking in order to minimize the adverse effects caused by the patent cliff.

Published By MarketLine
08 Jun 2012 $495
Buy
Report
Report

Strategies for Comparative Efficacy Trials

Comparative efficacy data are not necessarily required for approval but are increasingly demanded by payers. Meeting the expectations of all stakeholders can be challenging, making comparator selection and trial design complex decisions.

Published By Datamonitor
23 Aug 2012 $2800
Buy
Report
Report

Strategies and Technologies for Target Validation

High Phase II attrition is hampering the pharma industry’s ability to reach sustainable rates of innovation. More rigorous validation of new biological targets prior to clinical development is essential for increasing R&D efficiency.

Published By Datamonitor
28 Sep 2012 $2800
Buy
Report
Report

Stakeholder Opinions: Tropical Diseases - Dengue, Japanese encephalitis and West Nile virus – Increasing attention for neglected diseases

This report explores key issues in dengue, Japanese encephalitis and West Nile infection. It contains an analysis of epidemiological trends, assessment of marketed vaccines and discusses the pipeline for vaccines and virus-specific therapeutics.

Published By Datamonitor
14 Dec 2010 $2800
Buy
Report
Report

Stakeholder Opinions: Hepatocellular cancer

Stakeholder Opinions: Hepatocellular Cancer discusses issues in the treatment of hepatocellular cancer, highlighting potential target populations for drug developers, treatment limitations and unmet needs, and an overview of the current pipeline.

Published By Datamonitor
01 Dec 2010 $2800
Buy
Report
Report

Stakeholder Opinions: Biosimilars in Cardiovascular and Metabolic Disease - Next generation of cardiovascular biosimilars impact market

Commercial analysis of biosimilars in cardiovascular and metabolic disease in the US, Japan, France, Germany, Italy, Spain, and the UK.

Published By Datamonitor
20 Dec 2010 $2800
Buy
Report
Report

Stakeholder Insight: Major Depressive Disorder - Gaining traction among physicians is crucial in an SSRI-dominated market

Primary research-based analysis of the major depressive disorder market, based on a survey of 180 psychiatrists in the US, Japan, and EU. Includes epidemiology, patient segmentation, treatment trends, perception of key brands, and patient outcomes.

Published By Datamonitor
23 Dec 2010 $6400
Buy
Report
Report

Stakeholder Insight: Epilepsy - Neurologists remain loyal to brands in genericized market

Primary research-based analysis of the epilepsy market, based on a survey of 180 neurologists in the US, Japan, and EU. Includes epidemiology, patient segmentation, treatment trends, perception of key brands, and patient outcomes.

Published By Datamonitor
16 Dec 2010 $6400
Buy
Report
Report

Stakeholder Insight: Breast Cancer (Hormone Receptor-Negative) - Triple-negative breast cancer offers a significant opportunity to new market entrants while Herceptin dominates the HER-2-positive market

Primary research-based analysis of the hormone receptor-positive breast cancer market. Includes epidemiology, patient segmentation, treatment trends, and future treatment scenarios. Separate coverage of triple-negative and HER-2-positive subsets.

Published By Datamonitor
03 Nov 2010 $6400
Buy

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.